Collecting information on a catheter used to treat atrial fibrillation
Part of Heart & circulation clinical trials.
This study collects information from people with atrial fibrillation who are having a catheter ablation procedure using the TactiFlex catheter. It helps doctors learn more about how well this catheter works in real-life patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (irregular heartbeat) and your doctor thinks you are a good candidate for a catheter ablation procedure.
- Your doctor plans to use a special catheter called the TactiFlex (with sensor) during the ablation.
- This can be your first ablation for atrial fibrillation, or you may have had one before.
- You are 18 years of age or older.
- You are willing to attend all study visits as scheduled.
- You are not participating in any other heart device, drug, or research study that might interfere with this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tracks results after a heart ablation procedure used to treat atrial fibrillation (an irregular heart rhythm). You may be asked to help by consenting and following the study plan so the researchers can better understand what happens after ablations.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study is a registry that collects information from patients with atrial fibrillation who are having an ablation procedure. It aims to improve care and research by tracking outcomes. You may be able to join if you are scheduled for an ablation, and some participants may be asked to take part in additional optional sub-studies.
This study tests a new catheter system, called Varipulse, to see if it's safe and effective for treating atrial fibrillation (AF), a heart rhythm problem. People with short-lasting AF who haven't been helped by medication may be able to join.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.